000 01229 a2200325 4500
005 20250516020755.0
264 0 _c20110614
008 201106s 0 0 eng d
022 _a1473-4877
024 7 _a10.1185/03007995.2010.548374
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNagori, B P
245 0 0 _aGeneric drug approval: a US perspective.
_h[electronic resource]
260 _bCurrent medical research and opinion
_cMar 2011
300 _a541-5 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aChemistry, Pharmaceutical
_xlegislation & jurisprudence
650 0 4 _aDrug Approval
_xlegislation & jurisprudence
650 0 4 _aDrug Utilization Review
_xlegislation & jurisprudence
650 0 4 _aDrugs, Generic
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMedicare
_xlegislation & jurisprudence
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
_xlegislation & jurisprudence
700 1 _aMathur, V
700 1 _aGarg, S
773 0 _tCurrent medical research and opinion
_gvol. 27
_gno. 3
_gp. 541-5
856 4 0 _uhttps://doi.org/10.1185/03007995.2010.548374
_zAvailable from publisher's website
999 _c20503468
_d20503468